|
CCDC7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.154300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.825900E-02 |
| Normal-vs-Stage2 |
2.314400E-01 |
| Normal-vs-Stage3 |
9.847800E-02 |
| Normal-vs-Stage4 |
2.738400E-01 |
| Stage1-vs-Stage2 |
9.883600E-01 |
| Stage1-vs-Stage3 |
5.827200E-01 |
| Stage1-vs-Stage4 |
9.920000E-01 |
| Stage2-vs-Stage3 |
6.792200E-01 |
| Stage2-vs-Stage4 |
9.836400E-01 |
| Stage3-vs-Stage4 |
7.475200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.402300E-02 |
| Normal-vs-AfricanAmerican |
1.137430E-01 |
| Normal-vs-Asian |
8.341200E-01 |
| Caucasian-vs-AfricanAmerican |
9.234600E-01 |
| Caucasian-vs-Asian |
6.241200E-01 |
| AfricanAmerican-vs-Asian |
5.614000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.106300E-02 |
| Normal-vs-Female |
9.963200E-01 |
| Male-vs-Female |
7.460600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.778200E-02 |
| Normal-vs-Extreme_Weight |
1.806140E-02 |
| Normal-vs-Obese |
8.709600E-01 |
| Normal-vs-Extreme_Obese |
7.935400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.551000E-01 |
| Normal_Weight-vs-Obese |
5.050400E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.677800E-01 |
| Extreme_Weight-vs-Obese |
2.473700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.607400E-01 |
| Obese-vs-Extreme_Obese |
8.318000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.113200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.836400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.533950E-02 |
| Normal-vs-Age(81-100Yrs) |
5.221200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.260000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.306800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.561500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.095300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.880300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.877000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.650500E-02 |
| Normal-VS-Type2 PRCC |
4.809800E-02 |
| Normal-VS-KIRP CIMP |
1.165640E-01 |
| Normal-VS-Unclassified PRCC |
4.778000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.228600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.792200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.935000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.461800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.938400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.469600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.499600E-02 |
| Normal-vs-N1 |
1.858130E-02 |
| Normal-vs-N2 |
4.402200E-01 |
| N0-vs-N1 |
7.442800E-01 |
| N0-vs-N2 |
8.504600E-01 |
| N1-vs-N2 |
6.923000E-01 |
|
|
